Enavate Sciences GP, LLC - 09 Mar 2026 SCHEDULE 13D/A Report for CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP)

Filing Manager: Enavate Sciences GP, LLC
Reporting Manager: Enavate Sciences GP, LLC
Security: CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share
Symbol: CAMP
Shares outstanding: 51,990,875 shares
Disclosed Ownership: 2,495,562 shares
Ownership: 4.8%
Form type: SCHEDULE 13D/A
Filing time: 11 Mar 2026, 17:57:20 UTC
Date of event: 09 Mar 2026
Previous filing: 23 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Enavate Sciences GP, LLC	4.8%	2,495,562	0	2,495,562	/s/ James P. Boylan	By James P. Boylan, Manager	0001953107
Everest Aggregator, LP	4.8%	2,495,562	0	2,495,562	/s/ James P. Boylan	By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager	0002040426